Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn about a recent article by Stephen MacDonald et al., published in BJHaem, adding:
“Suspected TTP is a medical emergency – don’t wait for ADAMTS13 to treat when clinical suspicion is high.
A practical summary of the 2026 BSH laboratory guidance on thrombotic thrombocytopenic purpura:
- Think TTP when thrombocytopenia plus microangiopathic haemolytic anaemia occur together.
- Look for marked thrombocytopenia, schistocytes, reticulocytosis, elevated LDH, low haptoglobin, and usually normal coagulation.
- Send a pre-treatment ADAMTS13 sample – ideally 3.2% sodium citrate, not EDTA – but never delay treatment.
- ADAMTS13 activity less than 10 IU/dL strongly supports TTP.
- 10–20 IU/dL is a grey zone, not an automatic negative.
- If less than 10 IU/dL, test anti-ADAMTS13 antibodies within 72 hours.
- Antibody-negative does not prove congenital TTP – genetic testing is required.
- For monitoring, use the same assay platform whenever possible.
Key message: rapid recognition, early sampling, and urgent treatment save lives.”
Title: Diagnosis and monitoring of thrombotic thrombocytopenic purpura: Guidance for laboratories from the British Society for Haematology
Authors: Stephen MacDonald, Thomas Pitchford, Deepak Singh, Rebekah Fretwell, P. Vince Jenkins, Caroline Lawrence, Richard Gooding, Sean Platton

Stay updated with Hemostasis Today.
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine